Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 372

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update

del Barrio-Tofiño, Ester, López-Causapé, Carla, Oliver, Antonio·2020·International Journal of Antimicrobial Agents

Abstract

Pseudomonas aeruginosa global clones associated with multidrug resistant (MDR) or extensively drug resistant (XDR) phenotypes, denominated high-risk clones, are a growing threat in hospitals world-wide. Here we provide a 2020 update of nosocomial MDR/XDR high risk clones. According to their prevalence, global spread and association with MDR/XDR profiles and concerning extended spectrum β-lactamases and carbapenemases, the world-wide top 10 P. aeruginosa high-risk clones includes ST235, ST111, ST233, ST244, ST357, ST308, ST175, ST277, ST654 and ST298. ST235 is certainly the most relevant high-risk clone, showing a world-wide dissemination associated with over 60 different β-lactamase variants, including multiple carbapenemases from classes A and B. Moreover, ST235 shows a highly virulent phenotype associated with a high mortality rate, likely due to the production of the ExoU+ cytotoxin. ST111 and ST233 are also world-wide disseminated MDR/XDR clones, particularly linked to VIM-2 metallo-β-lactamase (MBL), whereas ST244 is a very prevalent clone not always associated with MDR/XDR profiles. ST357, ST308 and ST298 are also ExoU+ and are therefore potentially associated with a higher virulence. In contrast, ST175, prevalent in some European countries, shows an MDR/XDR phenotype frequently caused by specific chromosomal mutations and is associated with a lower virulence. Finally, ST277 is highly prevalent in Brazil and is specifically associated with the MBL SPM. A deeper understanding of the underlying factors driving the success of high-risk clones, including the reported increased capacity for acquiring exogenous determinants, increased spontaneous mutation rates or higher ability to develop biofilms is required to develop global strategies to combat them.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijantimicag.2020.106196

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 372

Metadata

Authors
del Barrio-Tofiño, E., López-Causapé, C., & Oliver, A.
Venue
International Journal of Antimicrobial Agents
Publisher
Elsevier BV
Published
2020-12
Volume
56
Issue
6
Pages
106196
ISSN
0924-8579 (ISSN-L)
OpenAlex
W3092018586
Cited by
372
References
52
FWCI
9.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update. https://app.cochat.ai/papers/10.1016/j.ijantimicag.2020.106196
The paper
del Barrio-Tofiño, E., López-Causapé, C., & Oliver, A. (2020). Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2020.106196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.